Web Analytics Made Easy - StatCounter

Vincristine Inj Tenders

Get complete information related to latest Vincristine Inj Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Vincristine Inj Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Vincristine Inj Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

corporations/Associations/Others

CTN :45477028 Due date: 23 Jun, 202623 Jun, 2026 13.71 Crore
Tender For e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment[nrd-123], cabazitaxel injection 60 mg [nrd-167], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mginj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone inj ip 200mg/ml [420], piperacillin + tazobactum for injection ip 4gm+500mg[468], decitabine 50 mg inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

CTN :45401737 Due date: 11 Jun, 202611 Jun, 2026 NA
Tender For supply of e-tender/ e-06/rrsh/medicinecancer/2026-2027 - medicine of cancer, cap alectinib 150mg, cap aprepitant 125mg80 mg, cap ceritinib 150 mg, cap crizotinib 200 mg, cap crizotinib 250 mg, cap enzalutamide 160mg, cap enzalutamide 40 mg, cap etoposide 50 mg, cap everolimus 10 mg, cap everolimus 5 mg, cap hydroxyurea 500 mg, cap ibrutinib 140 mg, cap lenalidomide 10 mg, cap lenalidomide 15 mg, cap lenalidomide 25 mg, cap lenalidomide 5 mg, cap lenvatinib 10 mg, cap lenvatinib 4 mg, cap nilotinib 150 mg, cap nilotinib 200 mg, cap nintedanib 150 mg, cap nivolumab 100 mg, cap palbociclib 100 mg, cap palbociclib 125 mg, cap palbociclib 75 mg, cap pomalidomide 1 mg, cap pomalidomide 2 mg, cap pomalidomide 3 mg, cap pomalidomide 4 mg, cap sunitinib 12.5 mg, cap sunitinib 25 mg, cap sunitinib 50 mg, cap tegfur+uracil 100mg+224mg, cap temozolomide 100 mg, cap temozolomide 20 mg, cap temozolomide 250 mg, cap thalidomide 100 mg, cap thalidomide 50 mg, inj argatroban 250 mg, inj 5- fluorouracil 250mg, inj 5- fluorouracil 500mg, inj ado trastuzumab emtasine 100 mg, inj ado trastuzumab emtasine 160 mg, inj arsenic trioxide 10 mg, inj atezolizumab 1200 mg, inj azactidine 100 mg, inj azactidine 150 mg, inj azactidine 200 mg, inj bendamustine 100 mg, inj bevacizumab 100 mg, inj bevacizumab 400 mg, inj bleomycin 30 iu, inj bleomycin 15 iu, inj bortezomib 2 mg, inj bortezomib 2.5 mg, inj bortezomib 3.5 mg, inj busulfan 60 mg, inj cabazitaxel 60 mg, inj carboplatin 150 mg, inj carboplatin 450 mg, inj carfilzomib 60 mg, inj cisplatin 10 mg, inj cisplatin 50 mg, inj cladribine 10 mg, inj cyclophosphamide 1 gm, inj cyclophosphamide 200 mg, inj cyclophosphamide 500 mg, inj cytarabine 1 gm, inj cytarabine 100 mg, inj cytarabine 500 mg, inj dacarbazine 200 mg, inj dacarbazine 500 mg, inj dactinomycin 0.5 mg, inj daratumumab 100 mg, inj daratumumab 400 mg, inj daunorubicin 20 mg, inj deciine 30 mg, inj deciine 50 mg, inj degarelix 120 mg, inj degarelix 80 mg, inj denosumab 120 mg, inj denosumab 60 mg, inj docetaxel 120 mg, inj docetaxel 20 mg, inj docetaxel 80 mg, inj doxorubicin 10 mg, inj doxorubicin 50 mg, inj durvalumab 120 mg, inj durvalumab 500 mg, inj epirubicin 10 mg, inj epirubicin 100 mg, inj epirubicin 50 mg, inj eribulin 0.88mg, inj eribulin 1 mg, inj etanecept 25 mg, inj etanecept 50 mg, inj etoposide 100 mg, inj etoposide 20mg, inj filgrastim 300mcg, inj fludarabine 50 mg, inj fulvestrant 250 mg, inj gemciine 1 gm, inj gemciine 1.4 gm, inj gemciine 200 mg, inj goserelin 10.8 mg, inj goserelin 3.6 mg, inj ibandronic acid 6 mg, inj idarubicin 5 mg, inj ifosfamide 1 gm, inj ifosfamide 7 gm, inj ifosfamide 2 gm, inj imipenem+ cilastatin 500 mg, inj interferon alfa 2b 3 miu, inj interferon alfa 2b 5 miu, inj interferon beta 1a 125 ug, inj interferon beta 1a 30 ug, inj interferon beta 1a 63/94 ug, inj irinotecan 100 mg, inj irinotecan 40 mg, inj l-asparaginase 10000 iu, inj l-asparaginase 5000 iu, inj leucovorin calcium 100 mg, inj leucovorin calcium 15 mg, inj leucovorin calcium 200 mg, inj leucovorin calcium 350 mg, inj leucovorin calcium 50 mg, inj leuprolide 11.25 mg, inj leuprolide 22.5 mg, inj leuprolide 3.75 mg, inj leuprolide 45 mg, inj luspatercept- aamt 25 mg, inj luspatercept- aamt 75 mg, inj melphalan 50 mg, inj mesna 200 mg, inj mesna 400 mg, inj mesna 600 mg, inj methotrexate 15 mg, inj methotrexate 50 mg, inj mitomycin - c 10 mg, inj mitomycin - c 40 mg, inj nano particle paclitaxel 100 mg, inj natalizumab 300 mg, inj nimotuzumab 50 mg, inj nintedanib 100 mg, inj nivolumab 40 mg, inj olaparib 100 mg, inj oxaliplatin 100 mg, inj oxaliplatin 50 mg, inj paclitaxel (albumin bound nanoparticle) 100 mg, inj paclitaxel 100 mg, inj paclitaxel 260 mg, inj paclitaxel 30 mg, inj paclitaxel 300 mg, inj panitumumab 20 mg, inj pegaspagase 3750 iu, inj pegfilgrastim 6 mg, inj pembrolizumab 100 mg, inj pemetrexed 100 mg, inj pemetrexed 500 mg, inj pertuzumab 420 mg, inj plerixafor 24 mg, inj ramucirumab 100 mg, inj ramucirumab 500 mg, inj ritu

corporations/Associations/Others

CTN :44434778 Due date: 01 Jul, 202601 Jul, 2026 NA
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

corporations/Associations/Others

CTN :45087762 Due date: 19 May, 202619 May, 2026 8.46 Crore
Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500 mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123], cabazitaxel injection 60 mg [nrd-167], carmustine 100 mg inj. ip [nrd-175], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], rasburicase 1.5 mg inj. [nrd-347], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu
 Loading, Please wait...

Connect us via What's Up